DARPA Launches $250K Commercialization Accelerator for SBIR Winners

DARPA has launched a commercialization accelerator that provides up to $250,000 in additional funding for SBIR/STTR Phase II awardees — money specifically earmarked to hire an entrepreneur-in-residence and execute a structured commercialization roadmap.

The program addresses a persistent gap in the defense innovation pipeline: brilliant technologists who can build breakthrough prototypes but struggle to navigate the path from lab demonstration to sustainable product.

What the Accelerator Provides

Selected Phase II performers receive supplemental funding to bring on a dedicated business development lead or entrepreneur-in-residence. That person works alongside the technical team on customer engagement planning, market analysis and mapping, competitive landscape assessment, techno-economic modeling, intellectual property strategy, and financial plan development.

The program is structured around commercial development milestones rather than open-ended consulting. Teams must demonstrate measurable progress toward a go-to-market strategy that can attract follow-on investment or acquisition interest from defense primes, commercial buyers, or venture capital.

DARPA will identify candidates from its existing pool of Phase II awardees, prioritizing teams with compelling technology and credible early traction toward commercialization.

Why This Matters for Defense Small Business

The "valley of death" between Phase II completion and sustainable revenue has claimed countless promising defense technologies. DARPA's own data shows that many of its most innovative SBIR projects stall not because the technology fails but because small teams lack the business expertise to navigate Department of Defense acquisition, build customer pipelines, or articulate value propositions to investors.

This accelerator sits alongside DARPA's broader Transition & Commercialization Support Program, which offers additional resources for moving technology beyond Phase II into acquisition programs, other federal agencies, or commercial markets.

How to Position for Selection

Phase II awardees should document early customer discovery, letters of intent from potential users, and any revenue traction — even small amounts signal commercial viability. Teams that have completed NIH I-Corps, NSF I-Corps, or similar customer discovery programs will have a head start on the business model documentation DARPA expects.

Grant seekers navigating SBIR commercialization pathways can find additional resources and analysis at grantedai.com.